Physician profile
Amina Moheyuddin
NPI 1568815702
$2,531.06
in general payments reported to CMS, 2019-2025
20 companies · $735 in 2025
The $735 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.54 · 2021: $125 · 2022: $103 · 2023: $420 · 2024: $1,137 · 2025: $735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,291.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $782.40 | 2020-2025 | Zepbound, Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals Lp | $426.07 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $245.64 | 2022-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Abbvie INC. | $185.06 | 2023-2025 | |
| Pfizer INC. | $183.57 | 2023-2025 | |
| Novo Nordisk INC | $137.60 | 2024-2025 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $95.19 | 2022-2025 | Capvaxive, Gardasil 9, Lagevrio |
| Medtronic, INC. | $86.42 | 2025 | Venaseal |
| Exact Sciences Corporation | $75.44 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $64.59 | 2023 | |
| Sumitomo Pharma America, INC. | $39.98 | 2024 | Gemtesa |
| Abbott Laboratories | $36.32 | 2024-2025 | Freestyle Libre 3 |
| Amgen INC. | $31.20 | 2025 | Repatha, Otezla |
| Dynavax Technologies Corporation | $28.57 | 2024 | Heplisav-B |
| Hologic Sales and Service, LLC | $22.23 | 2024 | Aptima, Thinprep 2000 Processor |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $20.70 | 2025 | Korlym |
| Shield Therapeutics INC | $20.43 | 2023 | Accrufer |
| Janssen Pharmaceuticals, INC | $19.53 | 2023 | Spravato |
| Tempus Ai, INC | $17.40 | 2025 | Tempus Pixel |
| Dexcom, INC. | $12.72 | 2023 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amina Moheyuddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.